In the past one week, the stock of the pharmaceutical company has rallied 14 per cent as compared to 0.16 per cent decline in ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

The most notable contributor to exports was the launch of the Xanomeline Active Pharmaceutical Ingredient (API).

The cash-saving measures come after interim analysis showed the company’s lead cancer drug only showed modest improvement in ...

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...

The Bayer Co.Lab Shanghai located at Shanghai Innovation (SH-INNO) Park in Pudong's Zhangjiang area joins its global network ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

Messe Muenchen India successfully concluded its highly anticipated and largest edition of analytica Anacon India, India Lab ...

Divi's Laboratories share price rose 12.02% this week, driven by Citi Research's 'buy' rating and a target price of ₹6,400.

An analyst at YES Securities said that Dr Reddy's Labs has undergone a significant correction from the peak and has ...

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...